Bundle 09 (2024)

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes, but he currently serves as the Interim Chief of the Division of Genetics in Medicine in the Dept. of Internal Medicine. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition, he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and facilitates regular exams and surveillance for patients at risk for endocrine tumors.

Dr. Park is an assistant professor in the department of Medical Oncology and Therapeutics Research and Population Sciences at City of Hope National Medical Center. Dr. Park graduated medical school from The College of Osteopathic Medicine of the Pacific at Western University of Health Sciences in Pomona, California. She completed her internal medicine residency program at Kaiser Permanente-Fontana. During her internal medicine training, she developed deep interest in genetics and pursued medical genetics training at University of California, Irvine. She is board certified in Internal Medicine and clinical genetics and genomics.

Dr. Kamihara received her medical degree from Harvard Medical School and her PhD in genetics from MIT. She completed her pediatric residency training at Boston Children’s Hospital/Boston Medical Center and her fellowship in pediatric hematology/oncology at the Dana-Farber Cancer Institute and Boston Children’s Hospital. She is currently an attending physician in the Jimmy Fund Clinic. Her research and clinical interests focus on pediatric cancer predisposition syndromes.

Dr. Kamihara serves as an expert for the Department of Hematology-Oncology for Boston Children's Hospital Precision Medicine Service. For more information about the Precision Medicine Service please visit bostonchildrens.org/precisionmed.

SANDRA DREIKE, MS, CGC is a licensed board-certified genetic counselor who specializes in cancer genetics. Sandra joined the City of Hope Division of Clinical Cancer Genomics in 2019, where she provides genetic counseling and cancer genetic risk assessments as a Senior Genetic Counselor. She received her Master of Science degree is Genetic Counseling from University of California, Irvine and her bachelor’s degree in Biology from California Polytechnic State University, San Luis Obispo. She previously practiced as a genetic counselor in Honolulu, HI where she specialized in cancer genetics and general pediatric and adult genetics. In addition to patient care she is a faculty member of the City of Hope Intensive Course and Clinical Cancer Genomics Community of Practice, and research. Sandra is a member of the National Society of Genetic Counselors (NSGC) and Southern California Genetic Counselors (SCGC).